MSCI香港小型指数将新纳入5只股份 剔出8只股份
MSCI明晟公布全球标准指数成分股半年度检讨结果显示,MSCI香港小型指数新增5只股份,同时剔出8只股份,所有变动将於5月29日收市後生效。
MSCI香港小型指数新纳入5只股份,包括置富产业信托(00778.HK)、香港电视(01137.HK)、九兴控股(01836.HK)、维他奶(00345.HK)及裕元(00551.HK)。
MSCI香港小型指剔除出8只股份,包括鸿宝资源(01131.HK)、思捷(00330.HK)、I.T(00999.HK)、蓝鼎国际(00582.HK)、新海能源(00342.HK)、维珍妮(02199.HK)、胜狮货柜(00716.HK)及德永佳(00321.HK)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.